Developer docs
API playgroundTry for free, no card

Search company profiles

Cureus

Full company profile

uuid000als4

Namestring
Cureus
Legal namestring
Cureus, Inc.
Websiteurl
cureus.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

Cureus, Inc. operates a peer-reviewed, Gold Open Access medical journal platform known as the Cureus Journal of Medical Science. Founded in 2010 in San Francisco and now operating as a fully virtual organization with distributed editorial offices in San Francisco, Atlanta, and Munich, the company is backed by Springer Nature, which provides publishing infrastructure and credibility while Cureus retains operational independence. The platform covers 60+ medical specialties and has accumulated 165,000+ citations, 6.3 million monthly reads, and 1.2 million monthly readers, achieving a Clarivate Impact Factor of 1.3.

The core technology is an online peer-reviewed publishing platform with an integrated article management system. Notable proprietary components include the SIQ (Scholarly Impact Quotient), a trademarked post-publication rating system that weights specialist community input more heavily than non-expert ratings, and a single-blind peer review system that automates reviewer matching via specialty keywords and uses Greek letter codes for anonymous reviewer identification, with automated escalation if reviews are delayed. Submissions are checked for plagiarism through an integration with Crossref Similarity Check (iThenticate), and reference management is supported through EndNote citation style files. The platform reaches readers through indexing partnerships with PubMed Central, PubMed, and Google Scholar.

Cureus monetizes primarily on the author and sponsor side rather than through reader paywalls. Approximately one-third of submissions meet formatting and language standards and publish for free; the remainder pay approximately $385 for the Preferred Editing service, which is mandatory for review articles regardless of quality. Additional revenue comes from targeted advertising through partnerships with Everyday Health and Publisher Health, subscription-based Academic Channels for institutions seeking branded research destinations, and sponsored Publishing Competitions funded by medical device companies such as Zap Surgical Systems and Accuray. The customer base is highly distributed globally across medical researchers, clinical physicians, academic institutions, and a long tail of individual authors in 60+ specialties, with explicit geographic restrictions limited to North Korea, Crimea, Luhansk, and Donetsk.

Short descriptiontext

Cureus is a peer-reviewed, Gold Open Access medical journal platform operating across 60+ specialties with a 29-day median publication time. Backed by Springer Nature, it serves individual medical researchers, clinical physicians, and academic institutions globally through freemium author publishing and subscription-based Academic Channels.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
open access publishing, medical journal platform, peer review services, academic publishing software, healthcare research publishing
Industry3 codes
PRIMARYEDAGAFAB
Medical, Clinical & Biomedical Scholarly Publishing
Education/Educational Publishing & Learning Content/Academic & Scholarly Publishing (Journals, Monographs)
SECONDARYEDAGAGAA
Medical & Clinical Reference (Physicians, Nursing, Allied Health)
Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing
SECONDARYMPAJABAK
Scholarly Societies & Conference Proceedings Publishing
Media, Entertainment & Sports/Publishing (Books, News, Magazines)/Educational & Academic Publishing (Textbooks, Scholarly, STM)
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Academic Medical Publishing
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Author Publication Fees (Preferred Editing)
TypeProfessional Services
Description

Authors requiring extensive editing services pay approximately $385 for the Preferred Editing service. Approximately one-third of submissions meet formatting requirements and publish for free.

cureus.com
2Advertising & Sponsorship
TypeAdvertising
Description

Cureus partners with Everyday Health and Publisher Health to serve targeted advertisements from healthcare companies. Additional sponsorship through publishing competitions sponsored by medical device companies.

cureus.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details3 tiers
1Free Publication (Standard)
ModelFreemiumBilling cadenceOne time
Notes

Articles meeting formatting and language standards publish at no cost. Original articles limited to 10 authors and 30 references; Case reports limited to 5 authors and 20 references; Editorials limited to 5 authors and 5 references.

cureus.com
2Preferred Editing Service
ModelOne time/ perpetual licenseBilling cadenceOne time
Notes

Approximately $385 per article for submissions requiring extensive formatting, grammar, or language corrections. Required for all review articles regardless of quality.

cureus.com
3Social Media Article Promotion
ModelOtherBilling cadenceOne time
Notes

Optional add-on for eligible published articles at additional cost for social media promotional boost.

cureus.com
GTM typeB2B and B2C
B2B and B2C
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Brand1 of 5 records shown
1SIQ (Scholarly Impact Quotient)
Description

A proprietary post-publication rating system that reflects an article's scientific impact as judged by the medical community.

cureus.com
+4 more records
Core offering1 text field

Cureus operates an online peer-reviewed open access medical journal platform (Cureus Journal of Medical Science) where medical researchers can submit and publish articles across 60+ specialties with a median time to publish of 29 days. The platform charges approximately $385 for a Preferred Editing service (or publishes qualifying submissions for free), distributes all content under CC-BY 4.0 Gold Open Access, and employs a proprietary SIQ post-publication rating system alongside an automated single-blind peer review process.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Cureus is a peer-reviewed open access medical journal platform backed by Springer Nature, offering a unified publishing ecosystem with rapid 29-day median publication times. The core product is the Cureus Journal of Medical Science, supplemented by the SIQ (Scholarly Impact Quotient) post-publication rating system for community-driven article assessment. Optional paid services include the Preferred Editing Service for formatting assistance. The platform also features Cureus Collections for thematic article curation, Academic Channels for institutional branding, Publishing Competitions for research visibility, Cureus U for specialty-based curated content, and Picture Quizzes for continuing medical education.

Product and service3 records
1Cureus Journal of Medical Science
CategoryAcademic medical publishing
Description

Peer-reviewed open access medical research journal covering 60+ specialties, with a median time to publish of 29 days from submission, free Gold Open Access (CC-BY 4.0) for all readers, and indexing in PubMed Central, PubMed, and Google Scholar. Targeted at medical researchers, clinicians, and academic authors worldwide.

2Preferred Editing Service
CategoryAuthor services / editing
Description

Paid editorial service costing approximately $385 per article, providing formatting, grammar, and language corrections for submissions that do not meet Cureus formatting standards. Required for all review articles regardless of quality. Targeted at medical researchers and authors whose manuscripts need professional editing before publication.

3Academic Channels
CategoryInstitutional publishing subscriptions
Description

Subscription-based institutional publishing service that enables academic departments, medical schools, and medical societies to create branded research destinations showcasing their faculty research and clinical experiences. Targeted at academic institutions and medical societies seeking institutional research visibility.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierMinorTypeGTM or Marketing Partner
Description

Advertising partnership for serving targeted advertisements from healthcare companies to journal readers.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Advertising partnership for serving targeted advertisements from healthcare companies to journal readers.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Major academic publisher backing Cureus, providing infrastructure, credibility, and publishing expertise while Cureus maintains operational independence.

Strategic tierCoreTypeTechnology or Integration
Description

All article submissions analyzed for research plagiarism and text duplication using Crossref Similarity Check Powered by iThenticate.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Sponsor of 'Dedicated Cranial Radiosurgery: Clinical Experience with New & Innovative SRS Technologies' publishing competition.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Sponsor of 'Real-Time Adaptive Motion Management on Helical and Robotic RT Platforms' publishing competition.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

PLOS is a leading open access scholarly publisher operating PLOS ONE and other journals, competing directly with Cureus for author submissions in the medical and life sciences under a similar open access, author-fee model.

TypeDirect peer
Description

BMC is a major open access publisher of peer-reviewed medical journals and a Springer Nature sibling brand, making it the most direct competitor in both product offering and parent-group overlap.

TypeDirect peer
Description

Frontiers operates a large portfolio of open access medical journals with a tech-enabled peer review platform, competing head-to-head with Cureus for authors who value fast, structured, transparent review processes.

4MDPI
TypeDirect peer
Description

MDPI is a large open access publisher with broad medical journal coverage, known for rapid publication and author-fee monetization — directly comparable to Cureus's value proposition for medical researchers.

TypeDirect peer
Description

Dove Medical Press publishes open access peer-reviewed medical journals across multiple specialties, sharing Cureus's focus on fast turnaround and broad specialty coverage.

TypeDirect peer
Description

PeerJ is an open access publisher in the life and medical sciences, offering a low-cost membership-based publishing model comparable to Cureus's low-cost / free author-fee approach.

TypeEmerging player
Description

F1000Research uses a post-publication peer review model with a fully open publishing option, overlapping with Cureus's open access and post-publication assessment (SIQ) philosophy.

TypeDirect peer
Description

BMJ Open is the open access arm of BMJ publishing peer-reviewed medical research with broad specialty coverage, competing for the same author pool as Cureus.

9JMIR Publications
TypeEmerging player
Description

JMIR is an open access publisher with a strong digital health and medical research portfolio, overlapping with Cureus's clinical and technology-focused medical audience.

10Elsevier (open access medical journals)
TypeBroad incumbent
Description

Elsevier operates a broad portfolio of subscription and open access medical journals through its Lancet and Cell Press imprints, providing large-scale incumbent competition to Cureus in the medical research publishing market.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration6 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cureus

Academic Medical Publishingcureus.com

Cureus is a peer-reviewed, Gold Open Access medical journal platform operating across 60+ specialties with a 29-day median publication time. Backed by Springer Nature, it serves individual medical researchers, clinical physicians, and academic institutions globally through freemium author publishing and subscription-based Academic Channels.

What Cureus does

Cureus, Inc. operates a peer-reviewed, Gold Open Access medical journal platform known as the Cureus Journal of Medical Science. Founded in 2010 in San Francisco and now operating as a fully virtual organization with distributed editorial offices in San Francisco, Atlanta, and Munich, the company is backed by Springer Nature, which provides publishing infrastructure and credibility while Cureus retains operational independence. The platform covers 60+ medical specialties and has accumulated 165,000+ citations, 6.3 million monthly reads, and 1.2 million monthly readers, achieving a Clarivate Impact Factor of 1.3.

The core technology is an online peer-reviewed publishing platform with an integrated article management system. Notable proprietary components include the SIQ (Scholarly Impact Quotient), a trademarked post-publication rating system that weights specialist community input more heavily than non-expert ratings, and a single-blind peer review system that automates reviewer matching via specialty keywords and uses Greek letter codes for anonymous reviewer identification, with automated escalation if reviews are delayed. Submissions are checked for plagiarism through an integration with Crossref Similarity Check (iThenticate), and reference management is supported through EndNote citation style files. The platform reaches readers through indexing partnerships with PubMed Central, PubMed, and Google Scholar.

Cureus monetizes primarily on the author and sponsor side rather than through reader paywalls. Approximately one-third of submissions meet formatting and language standards and publish for free; the remainder pay approximately $385 for the Preferred Editing service, which is mandatory for review articles regardless of quality. Additional revenue comes from targeted advertising through partnerships with Everyday Health and Publisher Health, subscription-based Academic Channels for institutions seeking branded research destinations, and sponsored Publishing Competitions funded by medical device companies such as Zap Surgical Systems and Accuray. The customer base is highly distributed globally across medical researchers, clinical physicians, academic institutions, and a long tail of individual authors in 60+ specialties, with explicit geographic restrictions limited to North Korea, Crimea, Luhansk, and Donetsk.

Cureus firmographics

Firmographics
Name
Cureus
Legal name
Cureus, Inc.
Website
https://cureus.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Cureus is a peer-reviewed, Gold Open Access medical journal platform operating across 60+ specialties with a 29-day median publication time. Backed by Springer Nature, it serves individual medical researchers, clinical physicians, and academic institutions globally through freemium author publishing and subscription-based Academic Channels.
Ownership category
akta.pro rank

Cureus industry classification

Industry
Product category
Academic Medical Publishing
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYEDAGAFAB
Medical, Clinical & Biomedical Scholarly Publishing
Education/Educational Publishing & Learning Content/Academic & Scholarly Publishing (Journals, Monographs)
SECONDARYEDAGAGAA
Medical & Clinical Reference (Physicians, Nursing, Allied Health)
Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing
SECONDARYMPAJABAK
Scholarly Societies & Conference Proceedings Publishing
Media, Entertainment & Sports/Publishing (Books, News, Magazines)/Educational & Academic Publishing (Textbooks, Scholarly, STM)

Keywords

  • Open access publishing
  • Medical journal platform
  • Peer review services
  • Academic publishing software
  • Healthcare research publishing

Where Cureus is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Cureus business model

Business model
GTM type
B2B and B2C
Offering type
Digital Commerce or Content
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Author Publication Fees (Preferred Editing): Authors requiring extensive editing services pay approximately $385 for the Preferred Editing service. Approximately one-third of submissions meet formatting requirements and publish for free.
  2. Advertising & Sponsorship: Cureus partners with Everyday Health and Publisher Health to serve targeted advertisements from healthcare companies. Additional sponsorship through publishing competitions sponsored by medical device companies.

Pricing tiers

ModelBillingPrice
FreemiumOne timeFree Publication (Standard)
One time/ perpetual licenseOne timePreferred Editing Service
OtherOne timeSocial Media Article Promotion

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Cureus product offering

Product offering

Core offering

Cureus operates an online peer-reviewed open access medical journal platform (Cureus Journal of Medical Science) where medical researchers can submit and publish articles across 60+ specialties with a median time to publish of 29 days. The platform charges approximately $385 for a Preferred Editing service (or publishes qualifying submissions for free), distributes all content under CC-BY 4.0 Gold Open Access, and employs a proprietary SIQ post-publication rating system alongside an automated single-blind peer review process.

Product overview

Cureus is a peer-reviewed open access medical journal platform backed by Springer Nature, offering a unified publishing ecosystem with rapid 29-day median publication times. The core product is the Cureus Journal of Medical Science, supplemented by the SIQ (Scholarly Impact Quotient) post-publication rating system for community-driven article assessment. Optional paid services include the Preferred Editing Service for formatting assistance. The platform also features Cureus Collections for thematic article curation, Academic Channels for institutional branding, Publishing Competitions for research visibility, Cureus U for specialty-based curated content, and Picture Quizzes for continuing medical education.

Differentiator

Problem solved

Functional benefit

Brands

  • SIQ (Scholarly Impact Quotient): A proprietary post-publication rating system that reflects an article's scientific impact as judged by the medical community.
  • Preferred Editing
  • Cureus Collections
  • Cureus Channels
  • Cureus U

Products and services

  • Cureus Journal of Medical Science Peer-reviewed open access medical research journal covering 60+ specialties, with a median time to publish of 29 days from submission, free Gold Open Access (CC-BY 4.0) for all readers, and indexing in PubMed Central, PubMed, and Google Scholar. Targeted at medical researchers, clinicians, and academic authors worldwide.
  • Preferred Editing Service Paid editorial service costing approximately $385 per article, providing formatting, grammar, and language corrections for submissions that do not meet Cureus formatting standards. Required for all review articles regardless of quality. Targeted at medical researchers and authors whose manuscripts need professional editing before publication.
  • Academic Channels Subscription-based institutional publishing service that enables academic departments, medical schools, and medical societies to create branded research destinations showcasing their faculty research and clinical experiences. Targeted at academic institutions and medical societies seeking institutional research visibility.

Companies that use Cureus

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Cureus technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature2 records

Cureus partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered minor and core.

  • Everyday HealthminorGTM or Marketing PartnerAdvertising partnership for serving targeted advertisements from healthcare companies to journal readers.
  • Publisher HealthminorGTM or Marketing PartnerAdvertising partnership for serving targeted advertisements from healthcare companies to journal readers.
  • Springer NaturecoreStrategic or Co-development PartnerMajor academic publisher backing Cureus, providing infrastructure, credibility, and publishing expertise while Cureus maintains operational independence.
  • Crossref (iThenticate)coreTechnology or IntegrationAll article submissions analyzed for research plagiarism and text duplication using Crossref Similarity Check Powered by iThenticate.
  • Zap Surgical SystemsminorGTM or Marketing PartnerSponsor of 'Dedicated Cranial Radiosurgery: Clinical Experience with New & Innovative SRS Technologies' publishing competition.
  • Accuray, Inc.minorGTM or Marketing PartnerSponsor of 'Real-Time Adaptive Motion Management on Helical and Robotic RT Platforms' publishing competition.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Cureus competitors and assessment

Company assessment

Direct peers

  • PLOS (Public Library of Science): PLOS is a leading open access scholarly publisher operating PLOS ONE and other journals, competing directly with Cureus for author submissions in the medical and life sciences under a similar open access, author-fee model.
  • BioMed Central (BMC): BMC is a major open access publisher of peer-reviewed medical journals and a Springer Nature sibling brand, making it the most direct competitor in both product offering and parent-group overlap.
  • Frontiers Media: Frontiers operates a large portfolio of open access medical journals with a tech-enabled peer review platform, competing head-to-head with Cureus for authors who value fast, structured, transparent review processes.
  • MDPI: MDPI is a large open access publisher with broad medical journal coverage, known for rapid publication and author-fee monetization — directly comparable to Cureus's value proposition for medical researchers.
  • Dove Medical Press: Dove Medical Press publishes open access peer-reviewed medical journals across multiple specialties, sharing Cureus's focus on fast turnaround and broad specialty coverage.
  • PeerJ: PeerJ is an open access publisher in the life and medical sciences, offering a low-cost membership-based publishing model comparable to Cureus's low-cost / free author-fee approach.
  • BMJ Open: BMJ Open is the open access arm of BMJ publishing peer-reviewed medical research with broad specialty coverage, competing for the same author pool as Cureus.

Emerging players

  • F1000Research: F1000Research uses a post-publication peer review model with a fully open publishing option, overlapping with Cureus's open access and post-publication assessment (SIQ) philosophy.
  • JMIR Publications: JMIR is an open access publisher with a strong digital health and medical research portfolio, overlapping with Cureus's clinical and technology-focused medical audience.

Broad incumbents

  • Elsevier (open access medical journals): Elsevier operates a broad portfolio of subscription and open access medical journals through its Lancet and Cell Press imprints, providing large-scale incumbent competition to Cureus in the medical research publishing market.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Cureus social profiles

Digital presence

Cureus financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cureus leadership team

Management profile

Number of profiles

Profiles4 records

Cureus funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cureus M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cureus

What does Cureus do?

Cureus operates an online peer-reviewed open access medical journal platform (Cureus Journal of Medical Science) where medical researchers can submit and publish articles across 60+ specialties with a median time to publish of 29 days. The platform charges approximately $385 for a Preferred Editing service (or publishes qualifying submissions for free), distributes all content under CC-BY 4.0 Gold Open Access, and employs a proprietary SIQ post-publication rating system alongside an automated single-blind peer review process.

Is Cureus a public or private company?

Cureus is a private company. It is classified as corporate owned and is currently operating.

When was Cureus founded?

Cureus was founded in 2010. It employs 501 to 1,000 people.

Where is Cureus based?

Cureus is headquartered in San Francisco, United States, in the North America region.

How does Cureus make money?

Two revenue lines are on record. Author Publication Fees (Preferred Editing) is the primary driver. The others are advertising & Sponsorship.

Who are Cureus's main competitors?

Direct peers on record are PLOS (Public Library of Science), BioMed Central (BMC), Frontiers Media, MDPI, Dove Medical Press, PeerJ and BMJ Open. Emerging players are F1000Research and JMIR Publications. Elsevier (open access medical journals) is listed as a broad incumbent.

Does Cureus have an API?

No public API is recorded for Cureus.

What industry is Cureus in?

Cureus's product category is Academic Medical Publishing. Its primary akta.pro industry code is EDAGAFAB, Medical, Clinical & Biomedical Scholarly Publishing, with a secondary code of EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Nate"비싼 약 소용없었다"…술로 간 망가진 70세女, 가려움증 잡은 비결 : 네이트 뉴스A 70-year-old British woman with alcoholic liver disease died 38 days after a fall in a nursing home. A study published in Cureus found that basic emollient care reduced her severe itching and allowed her to pass peacefully. The case highlights that simple moisturizing can improve comfort in end-of-life care.Naver술로 간 나빠진 70세女⋯요양원 낙상 후 ‘평온하게’ 죽은 사연A 70-year-old British woman with alcoholic liver disease fell alone in a care home, was hospitalized, and died 38 days later. She had a ReSPECT plan and severe itching; basic emollient care helped reduce scratching and led to a peaceful death. The case study was published in Cureus.Naver85세男 다리 근육 속 ‘쌀알 무더기’ 충격 정체…죽은 ‘기생충’ 흔적이었다An 85-year-old man's X-ray revealed rice-grain-shaped calcified masses in his leg muscles, remnants of a dead parasite. The case, published in Cureus, shows the parasite's eggs entered via contaminated food or water, and the calcified remains are unrelated to current pain. Doctors advised against unnecessary treatment, noting the pain likely stems from age, immobility, and viral infection.The Manila TimesFilipino doctors cite new medical review supporting tobacco harm reductionA new medical review published in the US-based peer-reviewed journal Cureus analyzed 26 studies on heated tobacco products and found that HTP users consistently showed lower exposure to harmful chemicals compared to cigarette smokers, with excess lung cancer risk estimated at only 3 to 4 percent of that from conventional cigarettes. The review, conducted by researchers from Unidade de Saúde Familiar in Portugal, found that heated tobacco emissions are reduced by more than 90 percent compared to cigarette smoke. Filipino medical professionals, including representatives from the Harm Reduction Alliance of the Philippines, welcomed the findings as supporting evidence for tobacco harm reduction strategies among smokers unable to quit.MedicaldialoguesZirconia Offers Esthetic Advantages, Titanium Remains Gold Standard, suggests studyAn umbrella review published in Cureus indicates that while zirconia dental implants offer superior esthetic outcomes and early bone apposition, titanium implants remain the gold standard due to higher long-term survival rates and more favorable bone response at four weeks. The study analyzed systematic reviews from 2014 to March 2023, finding titanium survival rates between 92.6%-100% compared to zirconia's 87.5%-91.25%. Consequently, titanium is recommended for general predictability, whereas zirconia serves as a viable alternative for patients with high aesthetic demands.SkepchickChatBots are Diagnosing Diseases that Don’t Exist Based on Blog PostsA researcher at the University of Gothenburg created a fictional disease called "Bixonimania" and posted about it on Medium in March 2024, only to find that AI chatbots including Microsoft Bing's Copilot, Google Gemini, Perplexity AI, and ChatGPT subsequently presented the fabricated condition as real medical information based solely on the blog posts and fake preprint papers she created. The misinformation propagated to the point where Cureus journal published a peer-reviewed paper citing the fake research before retracting it following inquiry from Nature. Studies cited in the article show that while chatbots correctly identify medical diagnoses 95% of the time, they recommend correct courses of action only 56% of the time, with accuracy dropping to 34.5% for diagnosis and 44% for action when human users interact with them.The Times of IndiaMen more at risk of heart attacks in NE: GMCH study on PCI patientsA study conducted at Gauhati Medical College and Hospital (GMCH) reveals that men in Northeast India are significantly more vulnerable to heart attacks, with the average patient age ranging from 43 to 67 years. The research, published in the journal 'Cureus', identified hypertension and dyslipidemia as the primary risk factors among patients undergoing percutaneous coronary intervention. Findings indicate high procedural success rates for these interventions, suggesting the procedure is safe and effective for this high-risk demographic.PR NewswireClinical Trial Shows Pycnogenol® Significantly Relieves Lipedema Symptoms and Improves Quality of Life in WomenA newly published clinical study in Cureus Journal of Medical Science demonstrates that Pycnogenol®, a natural plant extract from French maritime pine bark, significantly relieves lipedema symptoms and reduces body fat in women over a 60-day period. The double-blind, placebo-controlled trial of 100 women aged 18–40 showed a 29% reduction in symptoms and an 8% reduction in body fat compared to the placebo group, with no adverse effects reported.The Times of IndiaPumpkin seeds for PMS relief: How this everyday food helps with pain, mood, and energyThe article discusses the potential of pumpkin seeds to alleviate premenstrual syndrome (PMS) symptoms such as cramps, headaches, and mood swings due to their rich content of magnesium, zinc, and healthy fats. It references a systematic review on seed cycling published in Cureus to support the nutritional benefits for hormonal balance and symptom management. The text provides guidance on timing consumption during the luteal phase and various methods for incorporating the seeds into daily diets.The Times of IndiaWhat is a ‘smartphone pinky’ and how it affects your handsThe article discusses 'smartphone pinky,' a condition where prolonged one-handed phone use causes strain, indentation, and potential nerve compression in the little finger. It highlights a study published in Cureus revealing low public awareness of these risks despite high daily screen time, and recommends behavioral adjustments like using both hands or taking breaks to mitigate physical discomfort.